eXoZymes, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EXOZ research report →
Companyexozymes.com
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.
- CEO
- Michael Heltzen
- IPO
- 2024
- Employees
- 31
- HQ
- Monrovia, NV, US
Price Chart
Valuation
- Market Cap
- $80.55M
- P/E
- -8.31
- P/S
- 0.00
- P/B
- 52.59
- EV/EBITDA
- -8.11
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -220.64%
- ROIC
- -362.40%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-9,158,734 · -56.26%
- EPS
- $-1.09 · -51.39%
- Op Income
- $-9,716,471
- FCF YoY
- 25.05%
Performance & Tape
- 52W High
- $18.40
- 52W Low
- $7.08
- 50D MA
- $9.27
- 200D MA
- $11.29
- Beta
- 2.86
- Avg Volume
- 4.31K
Get TickerSpark's AI analysis on EXOZ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 8, 26 | Korman Tyler Paz | sell | 750 |
| Apr 9, 26 | Korman Tyler Paz | sell | 750 |
| Apr 1, 26 | Perriman Damien Alan | other | 146,437 |
| Apr 1, 26 | Perriman Damien Alan | other | 62,759 |
| Apr 1, 26 | Perriman Damien Alan | other | 0 |
| Apr 1, 26 | Perriman Damien Alan | other | 8,887 |
| Apr 1, 26 | Opgenorth Paul Hideo | other | 3,999 |
| Apr 1, 26 | Nawaz Fouad | other | 5,999 |
| Apr 1, 26 | Korman Tyler Paz | other | 5,332 |
| Jul 2, 25 | Heltzen Michael | buy | 1,040 |
Our EXOZ Coverage
We haven't published any research on EXOZ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EXOZ Report →